Hello All. Quick question
I read somewhere on HC but having trouble locating that Novartis/msb will commence a separate ards trial to the covid ards trial? Does this mean that no data from Covid ards trial can be used?
I was thinking the greatest benefit of having this gold standard covid ards trial was it allowed msb to sneak ahead of other companies for eg athx in the race to treat ards? Not just Covid ards.
Does it mean that we would have to go through phase 1, 2, 3 etc in trials for ards?
Appreciate any feedback and apologies for not mentioning the moon or rockets
MSB Trading 2020 - a new dawn, page-10440
-
- There are more pages in this discussion • 2,631 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 98246 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19079 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |